News

Shree Ganesh Bio-Tech (India) Limited submitted a certificate to the BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming no physical certificates were received for dematerialization of securities during that period.

Shree Ganesh Bio-Tech (India) Limited informed the BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited that the trading window for dealing in the company`s securities will be closed from October 1, 2026, until 48 hours after the announcement of the unaudited financial results for the second quarter ended September 30, 2026.

Shree Ganesh Bio-Tech (India) Limited informed the BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited that its Register of Members and Share Transfer Books will be closed from September 21, 2026, to September 28, 2026, for the Annual General Meeting to be held on September 28, 2026, with e-voting commencing on September 25, 2026, at 9:00 a.m. and ending on September 27, 2026, at 5:00 p.m.

Net loss of Shree Ganesh Biotech India reported to Rs 0.57 crore in the quarter ended June 2026 as against net profit of Rs 0.33 crore during the previous quarter ended June 2025. Sales rose 3.62% to Rs 1.43 crore in the quarter ended June 2026 as against Rs 1.38 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1.431.38 4 OPM %-62.24-6.52 - PBDT-0.570.33 PL PBT-0.570.33 PL NP-0.570.33 PL Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 4 August 2026.